<![CDATA[Genmab — Juni 2018]]>@TheNote - der er ingen tvivl om at dine dystre forudsigelser har til følge at forstærke den negative opfattelse af aktien, og derfor er spørgsmålet om det er det rene og skære ammestuesnak jo vigtigt. Jeg har læst indlæg herinde og så læser jeg også en masse uunderbyggede postulater. De fleste af os suger nok alt hvad vi kan opfange om Genmab til os.

]]>https://dev.proinvestor.com/forum/topic/451519/genmab-juni-2018RSS for NodeSun, 14 Jun 2026 05:38:04 GMTFri, 01 Jun 2018 02:35:05 GMT60<![CDATA[Reply to Genmab — Juni 2018 on Sat, 30 Jun 2018 17:19:58 GMT]]>God nat 🙂

]]>https://dev.proinvestor.com/forum/post/10182035https://dev.proinvestor.com/forum/post/10182035Sat, 30 Jun 2018 17:19:58 GMT<![CDATA[Reply to Genmab — Juni 2018 on Sat, 30 Jun 2018 04:48:05 GMT]]>God morgen. 🙂

]]>https://dev.proinvestor.com/forum/post/10182038https://dev.proinvestor.com/forum/post/10182038Sat, 30 Jun 2018 04:48:05 GMT<![CDATA[Reply to Genmab — Juni 2018 on Sat, 30 Jun 2018 03:51:10 GMT]]>Go morgen:)

]]>https://dev.proinvestor.com/forum/post/10182036https://dev.proinvestor.com/forum/post/10182036Sat, 30 Jun 2018 03:51:10 GMT<![CDATA[Reply to Genmab — Juni 2018 on Sat, 30 Jun 2018 03:46:11 GMT]]>God morgen. 🙂

]]>https://dev.proinvestor.com/forum/post/10182034https://dev.proinvestor.com/forum/post/10182034Sat, 30 Jun 2018 03:46:11 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 16:42:58 GMT]]>hvad der sker med teknologierne er vi vel efterhånden temmelig indifferente omkring

]]>https://dev.proinvestor.com/forum/post/10182037https://dev.proinvestor.com/forum/post/10182037Fri, 29 Jun 2018 16:42:58 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 16:42:10 GMT]]>pipeline news! det er sgu nyheder i sig selv. Forrygende!

]]>https://dev.proinvestor.com/forum/post/10182030https://dev.proinvestor.com/forum/post/10182030Fri, 29 Jun 2018 16:42:10 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 16:18:27 GMT]]>Fda safety

]]>https://dev.proinvestor.com/forum/post/10182031https://dev.proinvestor.com/forum/post/10182031Fri, 29 Jun 2018 16:18:27 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 16:17:36 GMT]]>
FDA Apology

favicon

(www.fda.gov)

]]>https://dev.proinvestor.com/forum/post/10182032https://dev.proinvestor.com/forum/post/10182032Fri, 29 Jun 2018 16:17:36 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 15:53:16 GMT]]>Nej der kan ikke ligge neget værdi her - men det ville nu være rart med et bispecifikt antistof der kom videre, så platformen vallideres yderligere.

]]>https://dev.proinvestor.com/forum/post/10182033https://dev.proinvestor.com/forum/post/10182033Fri, 29 Jun 2018 15:53:16 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 15:48:15 GMT]]>Absolut ikke gode tegn med gentagne stop. Men det udgør vel minimalt i værdiansættelsen på Genmab.

]]>https://dev.proinvestor.com/forum/post/10182029https://dev.proinvestor.com/forum/post/10182029Fri, 29 Jun 2018 15:48:15 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 15:13:09 GMT]]>Studiet har tidligere været on hold grundet bivirkninger, hvilket medførte protokol ændringer - så det ser ikke godt ud.

]]>https://dev.proinvestor.com/forum/post/10182025https://dev.proinvestor.com/forum/post/10182025Fri, 29 Jun 2018 15:13:09 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 14:35:11 GMT]]>Igen kan det jo også være, at de bare er mega forsigtige

]]>https://dev.proinvestor.com/forum/post/10182026https://dev.proinvestor.com/forum/post/10182026Fri, 29 Jun 2018 14:35:11 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 14:34:44 GMT]]>Nej, jeg undrede mig også, men det er hvad de skriver...

]]>https://dev.proinvestor.com/forum/post/10182027https://dev.proinvestor.com/forum/post/10182027Fri, 29 Jun 2018 14:34:44 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 14:33:29 GMT]]>Det var da ikke volsomt

]]>https://dev.proinvestor.com/forum/post/10182024https://dev.proinvestor.com/forum/post/10182024Fri, 29 Jun 2018 14:33:29 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 14:33:10 GMT]]>Grade 3 ?

]]>https://dev.proinvestor.com/forum/post/10182021https://dev.proinvestor.com/forum/post/10182021Fri, 29 Jun 2018 14:33:10 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 14:32:06 GMT]]>Lidt mindre godt. Dose Escalation Study of JNJ-63709178, a Humanized CD123 x CD3 DuoBody. Recruitment Status : Suspended (Study on hold due to Grade 3 event.)

]]>https://dev.proinvestor.com/forum/post/10182022https://dev.proinvestor.com/forum/post/10182022Fri, 29 Jun 2018 14:32:06 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 14:10:55 GMT]]>Dara var også mega lang tid om at komme videre 🙂

]]>https://dev.proinvestor.com/forum/post/10182028https://dev.proinvestor.com/forum/post/10182028Fri, 29 Jun 2018 14:10:55 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 13:49:25 GMT]]>Det har taget 18 måneder, men de er givetvis også gået meget forsigtigt frem.

]]>https://dev.proinvestor.com/forum/post/10182020https://dev.proinvestor.com/forum/post/10182020Fri, 29 Jun 2018 13:49:25 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 13:47:59 GMT]]>Det betyder i det mindste, at det har vist sig sikkert at bruge det og at de har fundet den/de relevante dosis. The dose escalation part has two dose escalation arms: the first arm investigates a once every 3 weeks (1Q3W) dosing schedule and the second arm investigates a three administrations over 4 weeks (3Q4W) dosing schedule.

]]>https://dev.proinvestor.com/forum/post/10182017https://dev.proinvestor.com/forum/post/10182017Fri, 29 Jun 2018 13:47:59 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 13:42:31 GMT]]>Betyder det at de har set en effekt eller skal vi stadig vente på det ?

]]>https://dev.proinvestor.com/forum/post/10182018https://dev.proinvestor.com/forum/post/10182018Fri, 29 Jun 2018 13:42:31 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 13:03:14 GMT]]>Også opdateret på CT med et pænt antal nye klinikker, der rekrutterer

]]>https://dev.proinvestor.com/forum/post/10182019https://dev.proinvestor.com/forum/post/10182019Fri, 29 Jun 2018 13:03:14 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 13:02:12 GMT]]>human AXL fremskridt, kan vel kun være gode tegn

]]>https://dev.proinvestor.com/forum/post/10182014https://dev.proinvestor.com/forum/post/10182014Fri, 29 Jun 2018 13:02:12 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 12:28:36 GMT]]>
Link Preview Image
HuMax®-AXL-ADC Progress Triggers Milestone Payment to Seattle Genetics

Company Announcement Genmab to pay Seattle Genetics, Inc. a milestone payment of USD 7 million under the Antibody-Drug Conjugate (ADC)...

favicon

GlobeNewswire News Room (www.globenewswire.com)

]]>https://dev.proinvestor.com/forum/post/10182013https://dev.proinvestor.com/forum/post/10182013Fri, 29 Jun 2018 12:28:36 GMT<![CDATA[Reply to Genmab — Juni 2018 on Fri, 29 Jun 2018 11:58:28 GMT]]>Ville hellere have haft vores Dara anbefaling

]]>https://dev.proinvestor.com/forum/post/10182012https://dev.proinvestor.com/forum/post/10182012Fri, 29 Jun 2018 11:58:28 GMT